FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Thom Brian David 2. Issuer Name and Ticker or Trading Symbol United Health Products, Inc. [ UEEC ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)         (First)         (Middle)
10624 S EASTERN AVE., STE A209
3. Date of Earliest Transaction (MM/DD/YYYY)
3/31/2021
(Street)
HENDERSON, NV 89052
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  3/31/2021  3/31/2021  M    916911  A $0.50  1041911  D   
Common Stock  3/31/2021  3/31/2021  M    303361  A $0.50  1345272  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Convertible Notes  $0.50  3/31/2021  3/31/2021  M        458455 (1)  3/31/2021  3/31/2021  Common Stock  916911   (4) 11551680 (3) D   
Convertible Notes  $0.50  3/31/2021  3/31/2021  M        151680 (2)  3/31/2021  3/31/2021  Common Stock  303361   (4) 11500000 (3) D   

Explanation of Responses:
(1)  Reflects $450,000 initial principal value of Notes plus $8,455 of accrued 3.0% interest payable "in kind" as at the conversion date.
(2)  Reflects $150,000 initial principal value of Notes plus $1,680 of accrued 3.0% interest payable "in kind" as at the conversion date.
(3)  Includes 11,500,000 of unvested Restricted Stock Units; there is no assurance that the performance-based vesting conditions will ever be met.
(4)  N/A

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Thom Brian David
10624 S EASTERN AVE.
STE A209
HENDERSON, NV 89052
X
Chief Executive Officer

Signatures
/s/ Brian David Thom 4/7/2021
**Signature of Reporting Person Date